PHORBOL ESTER RESPONSIVE B LYMPHOCYTES

佛波酯反应性 B 淋巴细胞

基本信息

项目摘要

The goal of the proposed studies is to learn how Ly-1 lineage B cells are stimulated to proliferate and to elucidate the intracellular mechanisms responsible for S phase entry in these cells. (1) In the first specific aim we will extend our previous work showing that Ly-1+ B cells are uniquely stimulated to initiate DNA synthesis by phorbol ester, without a co-mitogen, by more fully exploring the nature of the phorbol ester responsive B cell. The phenotype of responsive B cells will be examined and the issue of pre-activation will be addressed through evaluation of markers that are signs of B cell activation. (2) In the second specific aim we will explore the intracellular mechanisms that are responsible for phorbol ester induced S phase entry in Ly-1+ B cells. Preliminary results suggest a central role for protein kinase C. We will evaluate PKC activity and isozymes with particular attention to difference between phorbol ester responsive (Ly-1+) and nonresponsive (conventional) B cells. We will then begin to link PKC activity with "downstream" events by determining the stimulated expression of 3 early response gene--c-myc, c-fos, and c-jun-- and by characterizing Fos associated proteins that may regulate gene expression and our finding that Ly-1+ B cells fail to be stimulated through sIg by identifying the level at which sLg mediated signaling is subverted. We will evaluate second messenger generation by measuring production of IP3 and DAG and translocation of PKC, and we will examine the more distal events of early response gene expression. Ly-1+ B cells produce autoantibodies and are implicated in the pathogenesis of autoimmune diseases; ly-1+ B cells readily undergo neoplastic transformation and represent the cell of origin for many B cell tumors. Elucidation of the mechanisms that govern Ly-1+ B cells proliferation may aid in understanding the origin of autoimmune and malignant diseases of lymphocytes and suggest means of influencing their outcomes.
拟议研究的目标是了解Ly-1谱系B细胞是怎样的

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

THOMAS L ROTHSTEIN其他文献

THOMAS L ROTHSTEIN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('THOMAS L ROTHSTEIN', 18)}}的其他基金

FAIM Proteostasis in ALS
ALS 中的 FAIM 蛋白质稳态
  • 批准号:
    10527540
  • 财政年份:
    2022
  • 资助金额:
    $ 20.66万
  • 项目类别:
Human B1-like Cells and Pneumococcal Defense in the Elderly
人类 B1 样细胞和老年人的肺炎球菌防御
  • 批准号:
    10553643
  • 财政年份:
    2019
  • 资助金额:
    $ 20.66万
  • 项目类别:
Human B1-like Cells and Pneumococcal Defense in the Elderly
人类 B1 样细胞和老年人的肺炎球菌防御
  • 批准号:
    10330573
  • 财政年份:
    2019
  • 资助金额:
    $ 20.66万
  • 项目类别:
IgM vs IgG natural antibodies that bind pathogenic apolipoprotein B100
结合致病性载脂蛋白 B100 的 IgM 与 IgG 天然抗体
  • 批准号:
    9305007
  • 财政年份:
    2016
  • 资助金额:
    $ 20.66万
  • 项目类别:
Human B1 Lymphopoiesis
人类 B1 淋巴细胞生成
  • 批准号:
    8385892
  • 财政年份:
    2012
  • 资助金额:
    $ 20.66万
  • 项目类别:
Human B1 Lymphopoiesis
人类 B1 淋巴细胞生成
  • 批准号:
    8496698
  • 财政年份:
    2012
  • 资助金额:
    $ 20.66万
  • 项目类别:
Human B1 Cell Immunoglobulin
人B1细胞免疫球蛋白
  • 批准号:
    8521076
  • 财政年份:
    2012
  • 资助金额:
    $ 20.66万
  • 项目类别:
Human B1 Cell Immunoglobulin
人B1细胞免疫球蛋白
  • 批准号:
    8284733
  • 财政年份:
    2012
  • 资助金额:
    $ 20.66万
  • 项目类别:
FAIM in Immunity and Autoimmunity
免疫和自身免疫中的 FAIM
  • 批准号:
    8081080
  • 财政年份:
    2010
  • 资助金额:
    $ 20.66万
  • 项目类别:
FAIM in Immunity and Autoimmunity
免疫和自身免疫中的 FAIM
  • 批准号:
    8489252
  • 财政年份:
    2010
  • 资助金额:
    $ 20.66万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了